Cell proliferation and DNA content in rat urothelial lesions after repeat intravesical instillations of mitomycin C and bacillus calmette-guérin

Urologia Internationalis

Volumn 80, Issue 1, 2008, Pages 90-97

  Oliveira, P ^a   Palmeira, C ^b,c   Colaco A ^a   De La Cruz P, L F ^e   Lopes, C ^b,d  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Bacillus Calmette Gu rin; Image cytometry analysis; Ki 67; Mitomycin C

Indexed keywords

BCG VACCINE; BIOTIN; DNA; KI 67 ANTIGEN; MITOMYCIN C; PEROXIDASE; SODIUM CHLORIDE; STREPTAVIDIN;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; BODY WEIGHT; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; DYSPLASIA; FEMALE; FLUID INTAKE; FOOD INTAKE; GENOMIC INSTABILITY; HYPERPLASIA; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SQUAMOUS CELL METAPLASIA; STATISTICAL ANALYSIS; UROTHELIUM;

ADMINISTRATION, INTRAVESICAL; ANIMALS; BCG VACCINE; CELL PROLIFERATION; DNA; FEMALE; KI-67 ANTIGEN; MITOMYCIN; PHENOTYPE; RATS; RATS, INBRED F344; SODIUM CHLORIDE; TREATMENT OUTCOME; URINARY BLADDER DISEASES; UROTHELIUM;

EID: 38349166421     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111737     Document Type: Article

References (40)

1. Elkin M, Ayesh S, Schneider T, de Groot N, Hochberg A, Ariel I: The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 1998;19:2095-2099.
2. Rosenberg JE, Carroll PR, Small EJ: Update on chemotherapy for advanced bladder cancer. J Urol 2005;174:14-20.
3. Lum BL, Torti FM: Adjuvant intravesicular pharmacotherapy for superficial bladder cancer. J Natl Cancer Inst 1991;83:682-694.
4. Stein JP: The treatment of patients with bladder cancer: let's not forget the past! J Urol 2005;174:814-815.
5. Bohle A, Bock PR: Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 2004;63:682-686.
6. Witjes JA: Management of BCG failures in superficial bladder cancer: a review. Eur Urol 2006; in press.
7. Melekos MD, Moutzouris GD: Intravesical therapy of superficial bladder cancer. Curr Pharm Des 2000;6:345-359.
8. Okamura K, Miyake K, Koshikawa T, Asai J: Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67. J Urol 1990;144:875-878.
9. Friedman D, Mooppan UM, Rosen Y, Kim H: The effect of intravesical instillations of thiotepa, mitomycin C, and adriamycin on normal urothelium: an experimental study in rats. J Urol 1991;145:1060-1063.
10. Post JG, te Poele JA, Oussoren YG, Stewart FA: Radiation tolerance of normal mouse bladders after intravesical chemotherapy. Radiother Oncol 1995;34:30-38.
11. Kadhim SA, Chin JL, Batislam E, Karlik SJ, Garcia B, Skamene E: Genetically regulated response to intravesical bacillus Calmette-Guerin immunotherapy of orthotopic murine bladder tumor. J Urol 1997;158:646-652.
12. Hall LW, Clarke KW, Trim CM: Veterinary Anaesthesia. London, Saunders, 2001, pp 10-11.
13. Epstein JI, Amin MB, Reuter VR, Mostofi FK: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-1448.
14. Oliveira PA, Palmeira C, Lourenço L, Lopes C: Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. J Exp Clin Cancer Res 2005;24:207-214.
15. MichielsenD, Amy J-J, Coomans D, Storme G, Wyndaele J-J: Mitomycin C and epirubicin: functional bladder damage in rats after repeat intravesical instillations. J Urol 2005;173:2166-2170.
16. Murphy WM, Soloway MS, Crabtree WN: The morphologic effects of mitomycin C in mammalian urinary bladder. Cancer 1981;47:2567-2574.
17. Post JG, te Poele JA, Oussoren Y, Stewart FA: Bladder damage in mice after single and repeated intravesical instillations of mitomycin C or doxorubicin. J Urol 1993;150:1965-1969.
18. Oyasu R: Epithelial tumours of the lower urinary tract in humans and rodents. Food Chem Toxicol 1995;33:747-755.
19. Melekos MD: Prophylaxis of superficial bladder cancer with modified intravesical epirubicin treatment schedule. Oncology 1993;50:450-455.
20. Ali-El-Dein B, Sarhan O, Hinev A, Ibrahiem el-Hi, Nabeeh A, Ghoneim MA: Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index. BJU Int 2003;393-399.
21. Bohle A, Bock PR: Intravesical bacillus Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumour progression. Urology 2004;63:682-687.
22. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-883.
23. Wrobel KH, Bickel D, Kujat R: Immunohistochemical study of seminiferous epithelium in adult bovine testis using monoclonal antibodies against Ki-67 protein and proliferating cell nuclear antigen (PCNA). Cell Tissue Res 1996;283:191-201.
24. Mellon K, Neal DE, Robinson MC, Marsh C, Wright C: Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67. Br J Urol 1990;66:281-285.
25. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M, Lampertico P: Proliferation index as a prognostic marker in breast cancer. Cancer 1993;71:3926-3931.
26. Kruger S, Muller H: Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas. Br J Urol 1995:75:480-484.
27. Tsuji M, Kojima K, Murakami Y, Kanayama H, Kagawa S: Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens. Br J Urol 1997;79:367-372.
28. Cohen SM: Role of cell proliferation in regenerative and neoplastic disease. Toxicol Lett 1995;82-83:15-21.
29. Clayson DB, Fishbein L, Cohen SM: Effects of stones and other physical factors on the induction of rodent bladder cancer. Food Chem Toxicol 1995;33:771-784.
30. Bird Vincent G, Soloway Mark S, Malmström PU: Intravesical chemotherapy in the treatment of superficial bladder; in Droller MJ (ed): Bladder Cancer: Current Diagnosis and Treatment. Totowa, Humana Press, pp 183-223.
31. Bohle A, Brandau S: Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol 2003;170:964-969.
32. Murg MN, Schuler M, Eastmond DA: Persistence of chromosomal alterations affecting the 1cen-q12 region in a human lymphoblastoid cell line exposed to diepoxybutane and mitomycin C. Mutat Res 1999;446:193-203.
33. Pagano G, Degan P, De Biase A, Iaccarino M, Warnau M: Diepoxybutane and mitomycin C toxicity is associated with the induction of oxidative damage in sea urchin embryos. Hum Exp Toxicol 2001;20:651-655.
34. Lee S, Tolmachoff T, Marchevsky A: DNA content analysis ('polidy') by image analysis: clinical applications and comparison with flow cytometry; in Marchevesky AM, Bartels PH (eds): Image Analyses: A Primer for Pathologists. New York, Raven Press, 1994, pp 261-307.
35. Faranda A, Costa A, Canova S, Abolafio G, Silvestrini R: Image and flow cytometric analyses of DNA content in human solid tumors: a comparative study. Anal Quant Cytol Histol 1997;19:338-344.
36. Auer G, Askensten U, Ahrens O: Cytophotometry. Hum Pathol 1989;20:518-527.
37. Norming U, Tribukait B, Nyman CR, Nilsson B, Wang N: Prognostic significance of mucosal aneuploidy in stage Ta/T1 grade 3 carcinoma of the bladder. J Urol 1992;148:1420-1426.
38. Vindelov LL, Christensen IJ, Engelholm SA, Guldhammer BH, Hojgaard K, Sorensen BL, Wolf H: Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas. Cytometry 1995;22:93-102.
39. Haroske G, Baak JP, Danielsen H, Giroud F, Gschwendtner A, Oberholzer M, Reith A, Spieler P, Bocking A: Fourth updated ESin ACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol 2001;23:89-95.
40. Sudbo J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A: DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-1278.